+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Home Infusion Therapy Market Report and Forecast 2024-2032

  • PDF Icon


  • 140 Pages
  • May 2024
  • Region: Global
  • Expert Market Research
  • ID: 5973984
The global home infusion therapy market size was valued at USD 45.2 billion in 2023. It is expected to grow at a CAGR of 5.3% during the forecast period of 2024-2032, driven by government initiatives and funding for cancer research across the globe. The market is experiencing robust growth and is expected to reach USD 71.9 billion by 2032.

Global Home Infusion Therapy Market Analysis

The global home infusion therapy market has been witnessing significant growth, driven by the increasing preference for home-based medical care, advancements in infusion technologies, and the rising prevalence of chronic diseases that require long-term treatment regimens. Home infusion therapy involves the administration of drugs or biologicals through needles or catheters in a patient's home setting. This market analysis aims to provide an overview of the current trends, key drivers, challenges, and future outlook of the global home infusion therapy market.

Global Home Infusion Therapy Market Drivers

  • Increasing Chronic Disease Prevalence: The rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders necessitates long-term care, often administered through infusion therapies.
  • Advancements in Infusion Technologies: Innovations in infusion pumps and other related devices have made home infusion therapy more feasible and safer, encouraging its adoption.
  • Cost-Effectiveness and Convenience: Home infusion therapy offers a cost-effective alternative to hospital stays, reducing healthcare costs for both providers and patients. Additionally, it offers patients the convenience and comfort of receiving treatment in their homes.
  • Supportive Government Initiatives: Governments and health organizations worldwide are increasingly supporting home healthcare services, including home infusion therapy, through favorable policies and reimbursement frameworks.

Market Challenges

Despite the growth drivers, the market faces several challenges, including:

  • Regulatory and Safety Concerns: Ensuring the safety and efficacy of home infusion therapies poses significant challenges, requiring strict adherence to regulations and standards.
  • Lack of Skilled Healthcare Professionals: The shortage of nurses and other healthcare professionals trained in administering infusion therapy at home can limit market growth.
  • Access to Care: In some regions, particularly in developing countries, patients face difficulties accessing home infusion therapy services due to limited healthcare infrastructure and high costs.

Global Home Infusion Therapy Market Outlook

The global home infusion therapy market is expected to continue its growth trajectory in the coming years, fueled by ongoing technological advancements, a growing elderly population, and an increasing shift towards personalized and patient-centric healthcare models. The development of more user-friendly and safer infusion devices, coupled with expanding insurance coverage for home-based therapies, is likely to further propel market expansion.

Global Home Infusion Therapy Market Trends

The global home infusion therapy market is characterized by several evolving trends that are shaping its growth and development. These trends reflect the changing dynamics of healthcare delivery, technological advancements, and patient preferences. Understanding these trends is crucial for stakeholders in the healthcare sector, including providers, payers, manufacturers, and policymakers, to align their strategies with the emerging needs and opportunities within this market.

1. Technological Innovations and Smart Infusion Devices

Technological advancements are at the forefront of the home infusion therapy market trends. Smart infusion pumps and devices equipped with advanced features like remote monitoring, dose error reduction software, and wireless connectivity are becoming increasingly prevalent. These innovations enhance the safety, efficiency, and convenience of home infusion therapy by allowing healthcare providers to monitor therapy adherence and patient response in real-time, reducing the risk of complications.

2. Integration of Digital Health Platforms

The integration of home infusion therapy with digital health platforms is another significant trend. These platforms facilitate the seamless exchange of health data between patients, caregivers, and healthcare providers. They support medication management, appointment scheduling, and remote patient monitoring, contributing to more coordinated and personalized care. This trend is driven by the broader digital transformation in healthcare and the growing emphasis on patient-centric care models.

3. Expansion of Home Infusion Services

There is a noticeable expansion in the range of services offered through home infusion therapy. Beyond traditional applications like hydration therapy and antibiotic administration, home infusion services now increasingly include complex treatments such as immunoglobulin therapy, chemotherapy, and total parenteral nutrition. This expansion is partly due to improvements in infusion technologies and partly due to the healthcare industry's efforts to reduce hospital readmission rates and healthcare costs by providing more services in outpatient settings.

4. Increasing Focus on Patient Education and Support

Recognizing the critical role of patient engagement and education, there is a growing focus on providing comprehensive patient support programs. These programs aim to educate patients on their conditions, the importance of adherence to treatment plans, and how to manage their infusion therapy at home safely. Enhanced patient education and support not only improve clinical outcomes but also patient satisfaction and therapy compliance.

5. Regulatory and Reimbursement Landscape Changes

Changes in the regulatory and reimbursement landscape are also influencing market trends. Regulatory bodies are implementing stricter guidelines to ensure the safety and efficacy of home infusion therapies. At the same time, reimbursement policies are evolving to cover a broader range of home infusion services, making these therapies more accessible to a wider patient population. These changes are encouraging the adoption of home infusion therapy by reducing the financial burden on patients and ensuring high-quality standards.

Global Home Infusion Therapy Market Segmentation

Market Breakup by Type

  • Products
  • Intravenous set
  • Needleless catheter
  • Infusion pump
  • Services
The global home infusion therapy market, segmented by type into products (intravenous set, needleless catheter, infusion pump) and services, is poised for significant growth driven by key market drivers such as the rising prevalence of chronic diseases, technological advancements, and a shift towards cost-effective home-based care. The product segment, particularly infusion pumps, is expected to drive market growth, owing to innovations enhancing safety and efficiency. Meanwhile, the services segment will benefit from increasing demand for personalized and patient-centric care models. Together, these segments are set to catalyze the market's expansion during the forecast period, supported by advancements in healthcare technologies and growing acceptance of home-based therapy solutions.

Market Breakup by Indication

  • Anti-infective
  • Chemotherapy
  • Hydration Therapy
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others
The global home infusion therapy market, categorized by indication into anti-infective, chemotherapy, hydration therapy, parenteral nutrition, specialty pharmaceuticals, and others, is experiencing dynamic growth due to diverse driving forces. The anti-infective segment is a key contributor, driven by the increasing prevalence of infectious diseases and the need for prolonged treatments. Chemotherapy and specialty pharmaceuticals segments are also critical, fueled by the rising incidence of cancer and the development of targeted therapeutic drugs, respectively. Hydration therapy and parenteral nutrition segments are growing, supported by the aging population and the rising focus on comprehensive home healthcare. Across these indications, the market is set to expand significantly in the forecast period, propelled by technological advancements, a growing preference for home-based care, and an expanding range of treatable conditions through home infusion therapy, highlighting its crucial role in driving market growth.

Market Breakup by Route of Administration

  • Intramuscular
  • Subcutaneously
  • Epidural
The global home infusion therapy market, when analyzed by the route of administration, includes intramuscular, subcutaneously, and epidural segments. The subcutaneous segment is anticipated to witness substantial growth, driven by the convenience and self-administration capabilities it offers for chronic disease management, such as diabetes and immune deficiencies. The intramuscular route, typically used for faster medication absorption than subcutaneous injections, also plays a significant role, particularly in vaccinations and certain treatments requiring rapid effect. The epidural segment, though smaller, caters to specialized needs such as pain management during childbirth and certain chronic pain conditions, indicating a niche but vital market area. Each route of administration is poised to contribute to market growth, reflecting the diversifying needs and preferences for home infusion therapies. The overall expansion of the market in the forecast period will be supported by technological advancements in delivery systems, increasing patient preference for at-home care, and the growing need for treatments that can be administered via these routes.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The global home infusion therapy market, segmented by region, demonstrates varied growth dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America leads the market, driven by advanced healthcare infrastructure, high adoption of home healthcare services, and supportive reimbursement policies. Europe follows closely, with growth fueled by increasing chronic disease prevalence, healthcare decentralization, and technological advancements in infusion therapies. The Asia Pacific region is poised for rapid growth, attributed to improving healthcare systems, rising healthcare expenditure, and a growing elderly population demanding home-based care solutions. Latin America and the Middle East and Africa, though smaller in market size, are expected to witness significant growth due to increasing awareness of home healthcare benefits, government initiatives to improve healthcare accessibility, and gradually improving healthcare infrastructure. Across these regions, the market's expansion is propelled by the universal shift towards personalized, patient-centric care models, technological innovations in infusion devices, and the growing need for cost-effective treatment alternatives to hospital care.

Global Home Infusion Therapy Market Competitive Landscape

The competitive landscape of the global home infusion therapy market is marked by the presence of several key players, including Coram LLC, Option Care Health Inc., Optum Rx, Fresenius Kabi, ICU Medical, B.Braun Melsungen AG, Baxter International, KabaFusion, Promptcare Home Infusion, InfuSystem Holdings Inc., Smith’s Medical, CareCentrix, Nipro Group, and UVA Health among others. These companies play a pivotal role in shaping the market dynamics through their extensive product portfolios, technological innovations, and strategic initiatives. They compete on various fronts, such as service offerings, geographic presence, and the development of advanced infusion devices and solutions tailored to meet the evolving needs of patients and healthcare providers. The market is characterized by intense competition, with companies continuously investing in research and development to introduce more efficient and safer home infusion therapy options, expanding their reach to untapped markets, and forging partnerships to enhance their service capabilities and market positions.

Key Questions Answered in the Report

  • What is the current and future performance of the global home infusion therapy market?
  • What are the key drivers behind the growth of the global home infusion therapy market?
  • How does the shortage of healthcare professionals trained in home infusion therapy impact market growth?
  • What are the major trends influencing the growth of the home infusion therapy market, including technological and service expansions?
  • How are product innovations and the demand for personalized care models driving growth in the global home infusion therapy market?
  • What are the driving forces behind the growth of different segments in the global home infusion therapy market?
  • How do different routes of administration contribute to the growth of the global home infusion therapy market?
  • How do key players shape the competitive landscape of the global home infusion therapy market?
  • What are the main players/companies in the market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global home infusion therapy market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global home infusion therapy market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global home infusion therapy industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Home Infusion Therapy Market Overview
3.1 Global Home Infusion Therapy Market Historical Value (2017-2023)
3.2 Global Home Infusion Therapy Market Forecast Value (2024-2032)
4 Global Home Infusion Therapy Market Landscape*
4.1 Global Home Infusion Therapy: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Home Infusion Therapy: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indication
4.2.3 Analysis by Route of Administration
5 Global Home Infusion Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Home Infusion Therapy Market Segmentation (2017-2032)
6.1 Global Home Infusion Therapy Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Products Intravenous set Needleless catheter Infusion pump
6.1.3 Services
6.2 Global Home Infusion Therapy Market (2017-2032) by Indication
6.2.1 Market Overview
6.2.2 Anti-infective
6.2.3 Chemotherapy
6.2.4 Hydration Therapy
6.2.5 Parenteral Nutrition
6.2.6 Specialty Pharmaceuticals
6.2.7 Others
6.3 Global Home Infusion Therapy Market (2017-2032) by Route of Administration
6.3.1 Market Overview
6.3.2 Intramuscular
6.3.3 Subcutaneously
6.3.4 Epidural
6.4 Global Home Infusion Therapy Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Home Infusion Therapy Market (2017-2032)
7.1 North America Home Infusion Therapy Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Products Intravenous set Needleless catheter Infusion pump
7.1.3 Services
7.2 North America Home Infusion Therapy Market (2017-2032) by Indication
7.2.1 Market Overview
7.2.2 Anti-infective
7.2.3 Chemotherapy
7.2.4 Hydration Therapy
7.2.5 Parenteral Nutrition
7.2.6 Specialty Pharmaceuticals
7.2.7 Others
7.3 North America Home Infusion Therapy Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Home Infusion Therapy Market (2017-2032)
8.1 Europe Home Infusion Therapy Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Products Intravenous set Needleless catheter Infusion pump
8.1.3 Services
8.2 Europe Home Infusion Therapy Market (2017-2032) by Indication
8.2.1 Market Overview
8.2.2 Anti-infective
8.2.3 Chemotherapy
8.2.4 Hydration Therapy
8.2.5 Parenteral Nutrition
8.2.6 Specialty Pharmaceuticals
8.2.7 Others
8.3 Europe Home Infusion Therapy Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Home Infusion Therapy Market (2017-2032)
9.1 Asia Pacific Home Infusion Therapy Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Products Intravenous set Needleless catheter Infusion pump
9.1.3 Services
9.2 Asia Pacific Home Infusion Therapy Market (2017-2032) by Indication
9.2.1 Market Overview
9.2.2 Anti-infective
9.2.3 Chemotherapy
9.2.4 Hydration Therapy
9.2.5 Parenteral Nutrition
9.2.6 Specialty Pharmaceuticals
9.2.7 Others
9.3 Asia Pacific Home Infusion Therapy Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Home Infusion Therapy Market (2017-2032)
10.1 Latin America Home Infusion Therapy Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Products Intravenous set Needleless catheter Infusion pump
10.1.3 Services
10.2 Latin America Home Infusion Therapy Market (2017-2032) by Indication
10.2.1 Market Overview
10.2.2 Anti-infective
10.2.3 Chemotherapy
10.2.4 Hydration Therapy
10.2.5 Parenteral Nutrition
10.2.6 Specialty Pharmaceuticals
10.2.7 Others
10.3 Latin America Home Infusion Therapy Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Home Infusion Therapy Market (2017-2032)
11.1 Middle East and Africa Home Infusion Therapy Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Products Intravenous set Needleless catheter Infusion pump
11.1.3 Services
11.2 Middle East and Africa Home Infusion Therapy Market (2017-2032) by Indication
11.2.1 Market Overview
11.2.2 Anti-infective
11.2.3 Chemotherapy
11.2.4 Hydration Therapy
11.2.5 Parenteral Nutrition
11.2.6 Specialty Pharmaceuticals
11.2.7 Others
11.3 Middle East and Africa Home Infusion Therapy Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Corahm LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Option Care Health Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Optum Rx
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fresenius Kabi
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ICU Medical
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B.Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Baxter International
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 KabaFusion
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Promptcare Home Infusion
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 InfuSystem Holdings Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Smith’s Medical
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 CareCentrix
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Nipro Group
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 UVA Health
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
List not exhaustive!
18 Global Home Infusion Therapy Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The research team strives to make this section as comprehensive as possible.

Companies Mentioned

  • Corahm LLC
  • Option Care Health Inc.
  • Optum Rx
  • Fresenius Kabi
  • ICU Medical
  • B. Braun Melsungen AG
  • Baxter International
  • KabaFusion
  • Promptcare Home Infusion
  • InfuSystem Holdings Inc.
  • Smith’s Medical
  • CareCentrix
  • Nipro Group
  • UVA Health



Table Information